F11R and neoplasm: We chose to examine the impact of myeloid-specific JAM-A deletion in the syngeneic LLC and Py8119 tumor models because these tumors are heavily infiltrated by myeloid cells, similar to the majority of human lung and breast tumors (34, 35).